Presbia Eyes $50 Million IPO
Presbia today set the range for its forthcoming initial public offering, saying it plans to offer 4.2 million shares at $11 to $13 apiece.
At the midpoint, the IPO would fetch $50.4 million for Presbia, which makes the Flexiview Micro-Lens corneal implant to treat presbyopia.
Presbia, which plans to list on the NASDAQ exchange under the LENS symbol, is expected to launch the IPO Jan. 26. The Dublin-based company registered for the IPO last March, setting the value at $90 million.
Help employers find you! Check out all the jobs and post your resume.
At the midpoint, the IPO would fetch $50.4 million for Presbia, which makes the Flexiview Micro-Lens corneal implant to treat presbyopia.
Presbia, which plans to list on the NASDAQ exchange under the LENS symbol, is expected to launch the IPO Jan. 26. The Dublin-based company registered for the IPO last March, setting the value at $90 million.
Help employers find you! Check out all the jobs and post your resume.